Xylem Analyst Price Targets

Wall Street analyst price targets and consensus rating for Xylem (XYL).

Price Target Range — 13 Quarters

Analyst Consensus — 15 Analysts

12Buy

3Hold

Consensus RatingBuy# Analysts15Avg. Consensus PT$151Upside to Avg. PT+48.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 5, 2026	UBS	Joshua Spector	PT Cut	Neutral	$138→$112
Sep 15, 2026	Wolfe Research	Nigel Coe	Assumes	Peer Perform	—
Aug 24, 2026	Jefferies	Stephen Volkmann	PT Raise	Buy	$145→$150
Aug 13, 2026	UBS	Joshua Spector	PT Raise	Neutral	$135→$138
Jul 30, 2026	UBS	Joshua Spector	PT Raise	Neutral	$129→$135
Jul 29, 2026	Stifel	Nathan Jones	PT Raise	Buy	$157→$160
Jul 29, 2026	Mizuho	Brett Linzey	PT Raise	Neutral	$124→$130
Jul 29, 2026	RBC Capital	Deane Dray	PT Raise	Outperform	$159→$164
Jul 29, 2026	Barclays	William Grippin	PT Raise	Overweight	$154→$159
Jul 29, 2026	Baird	Michael Halloran	PT Raise	Outperform	$163→$165
Jul 20, 2026	Stifel	Nathan Jones	PT Cut	Buy	$159→$157
Jul 16, 2026	RBC Capital	Deane Dray	PT Raise	Outperform	$157→$159
Jun 25, 2026	Jefferies	Stephen Volkmann	Upgrade	Hold→Buy	$130→$140
Apr 29, 2026	UBS	Joshua Spector	PT Raise	Neutral	$132→$133
Apr 29, 2026	Citigroup	Andrew Kaplowitz	PT Cut	Buy	$174→$168
Apr 29, 2026	Oppenheimer	Bryan Blair	PT Cut	Outperform	$160→$158
Apr 29, 2026	Barclays	William Grippin	PT Cut	Overweight	$156→$154
Apr 29, 2026	Stifel	Nathan Jones	PT Cut	Buy	$163→$159
Apr 21, 2026	UBS	Joshua Spector	Downgrade	Buy→Neutral	$152→$132
Apr 16, 2026	JP Morgan	Mark Strouse	PT Cut	Overweight	$170→$160